Clinical outcomes of patients with pancreatic tumors discussed in Tumor Board

• Autor(a) principal: SILVA,JULIANA RIBEIRO
• Data de Publicação: 2022
• Outros Autores: RIECHELMANN,RACHEL SIMÕES PIMENTA, VIZZACCHI,BÁRBARA ALANA, MOLINA,PATRICIA, JESUS,VICTOR HUGO FONSECA DE, COIMBRA,FELIPE JOSE FERNANDEZ, ALVES,FULVIO APARECIDO SANTOS, CAMARGO,THAMIRES DE BRITO, VICENTE,GABRIELA AGUIAR, SANTOS,DENNYS RIBEIRO DOS, ANDRADE,VICTOR PIANA DE, CARVALHO,GENIVAL BARBOSA DE
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista do Colégio Brasileiro de Cirurgiões
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912022000100210
• topic: Interdisciplinary Communication; Decision-making; Pancreatic Neoplasms

ABSTRACT Objective: the recommendations of the decisions made by the Tumor Board (TB) should be followed to identify barriers that may interfere with the execution of the previously decided, best care for the patient. The aim of this study is to assess whether the TB conduct decision was performed in patients with pancreatic tumors, their life status 90 days after the TB decision, and to analyze the reasons why the conduct was not performed. Methods: we conducted a retrospective study with patients with pancreas tumors, evaluated between 2017 and 2019. We collected data on epidemiological status, whether the TB procedure was performed, the reason for not performing it, life status 90 days after the TB decision, and how many times each patient was discussed at a meeting. We compared categorical variables using the chi square test, numerical variables were presented as means and standard deviation. Results: we studied 111 session cases, in 95 patients, 86 (90.5%) diagnosed with cancer. After 90 days of TB, 83 patients (87.37%) remained alive, 9 had (9.47%) died, and 3 (3.16%) were lost to follow-up. The TB decision was not observed in 12 (10.8%) cases and the reasons were: 25% (3) for loss of follow-up, 8.33% (1) for patient refusal, and 66.67% (8) due to clinical worsening. The cases of patients with metastases had a lower rate of TB conduct compliance (p=0.006). Conclusions: the TB conduct was performed in most cases and the most evident reason for non-compliance with the conducts is the patient’s clinical worsening.